AgingResearch.NewsJoin free

Smilebiotek Zhuhai

CompanyChina

Smilebiotek Zhuhai develops one asset, in phase 2 (QA102 in dry age-related macular degeneration). Mostly small molecule; based in China.

1
Asset
Furthest
Phase 2
1
Trial
0
Signals

Pipeline

1

  • QA102

    Oral therapy for dry age-related macular degeneration

    Phase 2, Small molecule, dry age-related macular degeneration

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Similar companies5

Updated 7 Oct 2026 · 2 sources

Intelligence